An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimen.
Features and Benefits:
CLIA waived for swab specimens.
Pre-measured extraction reagent capsule for increased accuracy and ease of use
Flocked nasal swabs included for better specimen collection
Time to result: 10 to 15 minutes.
Positive Percent Agreement (PPA): FLU A (89.2%) & FLU B (86.4%)
Negative Percent Agreement (NPA): FLU A (99.4%) & FLU B (99.0%)
